Sphingolipids as New Biomarkers for Assessment of Delayed-Type Hypersensitivity and Response to Triptolide

27Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

Abstract

Background: Hypersensitivity diseases are associated with many severe human illnesses, including leprosy and tuberculosis. Emerging evidence suggests that the pathogenesis and pathological mechanisms of treating these diseases may be attributable to sphingolipid metabolism. Methods: High performance liquid chromatography-tandem mass spectrometry was employed to target and measure 43 core sphingolipids in the plasma, kidneys, livers and spleens of BALB/c mice from four experimental groups: control, delayed-type hypersensitivity (DTH) model, DTH+triptolide, and control+triptolide. Orthogonal partial least squares discriminant analysis (OPLS-DA) was used to identify potential biomarkers associated with variance between groups. Relationships between the identified biomarkers and disease markers were evaluated by Spearman correlation. Results: As a treatment to hypersensitivity disease, triptolide significantly inhibit the ear swelling and recover the reduction of splenic index caused by DTH. The sphingolipidomic result revealed marked alterations in sphingolipid levels between groups that were associated with the effects of the disease and triptolide treatment. Based on this data, 23 potential biomarkers were identified by OPLS-DA, and seven of these biomarkers correlated markedly with the disease markers (p<0.05) by Spearman correlation. Conclusions: These data indicate that differences in sphingolipid levels in plasma and tissues are related to DTH and treatment with triptolide. Restoration of proper sphingolipid levels may attribute to the therapeutic effect of triptolide treatment. Furthermore, these findings demonstrate that targeted sphingolipidomic analysis followed by multivariate analysis presents a novel strategy for the identification of biomarkers in biological samples. © 2012 Qu et al.

References Powered by Scopus

Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics

626Citations
N/AReaders
Get full text

Sphingolipidomics: High-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry

499Citations
N/AReaders
Get full text

IL-32, a proinflammatory cytokine in rheumatoid arthritis

304Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Mass-spectrometry-based lipidomics

124Citations
N/AReaders
Get full text

Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease

79Citations
N/AReaders
Get full text

Associations between plasma ceramides and cognitive and neuropsychiatric manifestations in Parkinson's disease dementia

45Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Qu, F., Wu, C. S., Hou, J. F., Jin, Y., & Zhang, J. L. (2012). Sphingolipids as New Biomarkers for Assessment of Delayed-Type Hypersensitivity and Response to Triptolide. PLoS ONE, 7(12). https://doi.org/10.1371/journal.pone.0052454

Readers' Seniority

Tooltip

Researcher 11

48%

PhD / Post grad / Masters / Doc 10

43%

Professor / Associate Prof. 2

9%

Readers' Discipline

Tooltip

Medicine and Dentistry 7

41%

Agricultural and Biological Sciences 5

29%

Pharmacology, Toxicology and Pharmaceut... 3

18%

Nursing and Health Professions 2

12%

Save time finding and organizing research with Mendeley

Sign up for free